STOCKHOLM, Sweden, Sept. 15, 2005 (PRIMEZONE) -- The biomaterials company Artimplant's new website www.artimplant.com entails a new structure, updated content and changed graphic profile.
The aim of the new website is to make it easier for patients, healthcare professionals and investors to find information on Artimplant, our implants and our biomaterial Artelon(R).
"The new website better reflects the changes we have made, and are implementing, to achieve our goals. It will provide potential investors and customers with a more complete picture of our company. It will also make it easier for everyone interested in our new products, featured in the press, to find the relevant information," says CEO Tord Lendau.
ARTIMPLANT
Artimplant's mission is to develop, produce and market implants based on the biomaterial Artelon(R) that meet the needs of patients, physicians and healthcare providers in orthopedics and other therapy areas.
Artimplant's vision is to become the partner of choice in biomaterials for hard and soft tissue repair in multiple therapy areas.
Artimplant is a public company, listed on the Stockholm Exchange, O-list.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=130692&fn=wkr0001.pdf